InnoCare Pharma Limited (HKG:9969)
13.72
-0.33 (-2.35%)
Apr 29, 2026, 4:08 PM HKT
InnoCare Pharma Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Cash & Equivalents | 6,189 | 7,072 | 6,241 | 8,287 | 8,698 | 5,929 | Upgrade
|
| Trading Asset Securities | 902.84 | - | 759.18 | - | 313.29 | 317.06 | Upgrade
|
| Cash & Short-Term Investments | 7,092 | 7,072 | 7,000 | 8,287 | 9,011 | 6,246 | Upgrade
|
| Cash Growth | 1.20% | 1.03% | -15.53% | -8.04% | 44.28% | 57.34% | Upgrade
|
| Accounts Receivable | 488.39 | 502.88 | 351 | 276.38 | 127.83 | 45.27 | Upgrade
|
| Other Receivables | 0.62 | 0 | 0.05 | 31.34 | 61.79 | 62.27 | Upgrade
|
| Receivables | 489.01 | 502.88 | 351.05 | 307.71 | 189.61 | 107.55 | Upgrade
|
| Inventory | 174.13 | 162.87 | 95.58 | 119.09 | 65.32 | 9.92 | Upgrade
|
| Other Current Assets | 441.24 | 324.09 | 373.56 | 51.38 | 33.56 | 53.87 | Upgrade
|
| Total Current Assets | 8,196 | 8,062 | 7,820 | 8,765 | 9,300 | 6,417 | Upgrade
|
| Property, Plant & Equipment | 729.47 | 752.26 | 814.27 | 798.5 | 937.27 | 566.08 | Upgrade
|
| Long-Term Investments | 649.24 | 1,201 | 0.4 | 5.66 | 11.71 | 326.1 | Upgrade
|
| Goodwill | 3.12 | 3.12 | 3.12 | 3.12 | 3.13 | 3.13 | Upgrade
|
| Other Intangible Assets | 247.69 | 248.05 | 258.14 | 266.03 | 41.31 | 34.17 | Upgrade
|
| Long-Term Deferred Charges | 29.53 | 30.31 | 31.94 | 33.3 | - | - | Upgrade
|
| Other Long-Term Assets | 527.89 | 526.24 | 479.43 | 48.06 | 28.04 | 50.95 | Upgrade
|
| Total Assets | 10,383 | 10,824 | 9,407 | 9,920 | 10,321 | 7,398 | Upgrade
|
| Accounts Payable | 210.55 | 183.7 | 128.36 | 134.9 | 118.6 | 84.6 | Upgrade
|
| Accrued Expenses | 39.58 | 137.6 | 87.69 | 100.08 | 116.03 | 97.5 | Upgrade
|
| Short-Term Debt | 388.29 | 176.93 | 137.45 | - | - | - | Upgrade
|
| Current Portion of Long-Term Debt | 138.41 | 112.26 | 56.35 | 1,256 | 1,197 | - | Upgrade
|
| Current Portion of Leases | - | 27.23 | 31.61 | 23.23 | 20.11 | 20.34 | Upgrade
|
| Current Income Taxes Payable | 58.38 | 11.88 | - | - | - | - | Upgrade
|
| Current Unearned Revenue | 34.6 | 105.43 | - | - | 12 | 19.48 | Upgrade
|
| Other Current Liabilities | 580.91 | 628.72 | 607.82 | 567.64 | 611.52 | 107.39 | Upgrade
|
| Total Current Liabilities | 1,451 | 1,384 | 1,049 | 2,082 | 2,075 | 329.3 | Upgrade
|
| Long-Term Debt | 988 | 1,276 | 1,322 | 331.88 | 287.76 | 1,238 | Upgrade
|
| Long-Term Leases | 17.5 | 19.03 | 27.44 | 43.65 | 35.44 | 47.44 | Upgrade
|
| Long-Term Unearned Revenue | 285.58 | 289.42 | 263 | 281.78 | 278.2 | 123.61 | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | 106.51 | - | - | - | - | Upgrade
|
| Total Liabilities | 3,020 | 3,074 | 2,662 | 2,739 | 2,677 | 1,739 | Upgrade
|
| Common Stock | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | Upgrade
|
| Additional Paid-In Capital | 12,219 | 12,199 | 12,111 | 12,150 | 11,756 | 9,372 | Upgrade
|
| Retained Earnings | -4,772 | -4,878 | -5,520 | -5,080 | -4,423 | -3,536 | Upgrade
|
| Treasury Stock | -19.75 | -19.75 | -3.1 | - | - | - | Upgrade
|
| Comprehensive Income & Other | -83.03 | 425.12 | 137.99 | 77.23 | 263.73 | -230.85 | Upgrade
|
| Total Common Equity | 7,344 | 7,727 | 6,725 | 7,148 | 7,597 | 5,605 | Upgrade
|
| Minority Interest | 18.98 | 22.35 | 20.63 | 32.86 | 47.23 | 54.36 | Upgrade
|
| Shareholders' Equity | 7,363 | 7,749 | 6,746 | 7,181 | 7,644 | 5,659 | Upgrade
|
| Total Liabilities & Equity | 10,383 | 10,824 | 9,407 | 9,920 | 10,321 | 7,398 | Upgrade
|
| Total Debt | 1,532 | 1,611 | 1,575 | 1,655 | 1,540 | 1,306 | Upgrade
|
| Net Cash (Debt) | 5,560 | 5,461 | 5,425 | 6,632 | 7,471 | 4,940 | Upgrade
|
| Net Cash Growth | 1.76% | 0.66% | -18.20% | -11.22% | 51.24% | 76.67% | Upgrade
|
| Net Cash Per Share | 3.30 | 3.23 | 3.20 | 3.89 | 5.05 | 3.62 | Upgrade
|
| Filing Date Shares Outstanding | 1,764 | 1,932 | 1,694 | 1,690 | 1,682 | 1,410 | Upgrade
|
| Total Common Shares Outstanding | 1,764 | 1,932 | 1,694 | 1,690 | 1,682 | 1,410 | Upgrade
|
| Working Capital | 6,745 | 6,678 | 6,771 | 6,683 | 7,224 | 6,088 | Upgrade
|
| Book Value Per Share | 4.16 | 4.00 | 3.97 | 4.23 | 4.52 | 3.98 | Upgrade
|
| Tangible Book Value | 7,093 | 7,476 | 6,464 | 6,879 | 7,553 | 5,567 | Upgrade
|
| Tangible Book Value Per Share | 4.02 | 3.87 | 3.81 | 4.07 | 4.49 | 3.95 | Upgrade
|
| Buildings | - | - | - | 364.63 | 224.41 | 81.04 | Upgrade
|
| Machinery | - | 405.49 | 362.86 | 302.01 | 248.13 | 127.57 | Upgrade
|
| Construction In Progress | - | 115.01 | 138.86 | 166.91 | 197.65 | 230.72 | Upgrade
|
| Leasehold Improvements | - | - | - | - | 35.44 | 6.68 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.